H1N1


GLEaM is a discrete stochastic epidemic computational model based on a meta-population approach in which the world is defined in geographical census areas connected in a network of interactions by human travel fluxes corresponding to transportation infrastructures and mobility patterns. The GLEaM 2.0 simulation engine includes a multiscale mobility model integrating different layer of transportation networks ranging from the long range airline connections to the short range daily commuting pattern (read more).

There have been produced several kind of projections collected in the H1N1 flu section:

The MPG team employed performance computational techniques and multi-layer, large-scale computer simulations to project the time course of the H1N1 flu epidemic in the United States. The simulations yielded projections and risk assessments of the epidemic outbreak in a worst-case scenario, in which no containment measures are taken to mitigate the spread. The approach was based on the current knowledge of the disease parameters and took into account the backbone of spatial spread: a precise estimate of human mobility on spatial scales between a few and a few thousand kilometers. The projections resolved the expected dynamics down to the county scale (3,109 counties in mainland United States). Details of the modeling approach are not yet published but are available online. The key factors in the MPG modeling approach are very accurate human mobility datasets on scales from a few to a few thousand kilometers based on human mobility proxies that included small scale daily commuting traffic, intermediate traffic, and long distance travel by air. The simulations consisted of multiple layers, each layer possessing and increasing degree of accuracy and complexity. The final projections are done with a fully stochastic model that incorporates the inherent randomness in disease dynamics that is particularly important at the onset of an epidemic when the number of infected individuals is small compared to the whole population.

The FBK team developed a stochastic, spatially structured individual-based model, considering explicit transmission in households, schools and workplaces, to simulate the spatiotemporal spread of an influenza pandemic in Italy and to evaluate the efficacy of interventions based on age-prioritized use of antivirals in terms of cumulative attack rate and excess mortality reduction under different scenarios. Results suggest that governments stockpile of influenza antiviral drugs suffice to treat approximately 25% of their populations. In countries with limited antivirals stockpile, providing prophylaxis to younger individuals is an option that could be taken into account in preparedness plans. In countries where the number of antivirals stockpiled is well below 25% of the population, priority should be decided based on age-specific case fatality rates. However, late detection of cases (administration of antivirals 48 hours after the clinical onset of symptoms) dramatically affects the efficacy of both treatment and prophylaxis (academic paper published on BMC Infectious Diseases). The FBK team has then extended the model to the entire European populations leveraging on the integration of air and railway transportation data. The analysis has shown that the impact of the epidemic in the European countries is highly variable because of marked differences in the socio-demographic structure of the European populations. The cumulative attack rate, R0, and the peak daily attack rate depend heavily on socio-demographic parameters, such as the size of household groups and the fraction of workers and students in the population (academic paper published on Proceedings of the Royal Society B).

Influenzanet is a system to monitor the activity of influenza-like-illness (ILI) with the aid of volunteers via the internet. It has been operational in The Netherlands and Belgium (since 2003), Portugal (since 2005), Italy (since 2008) and United Kingdom (since 2009), and the current objective is to implement Influenzanet in more European countries. In contrast with the traditional system of sentinel networks of mainly primary care physicians, Influenzanet obtains its data directly from the population. This creates a fast and flexible monitoring system whose uniformity allows for direct comparison of ILI rates between countries.

Any resident of a country where Influenzanet is implemented can participate by completing an online application form, which contains various medical, geographic and behavioural questions. Participants are reminded weekly to report any symptoms they have experienced since their last visit. The incidence of ILI is determined on the basis of a uniform case definition.

influenzanet1